Transplantation
Cost-Effectiveness Analysis
Everolimus Reduces Cancer Risk and Proves Cost-Effective in Liver Transplant
A cohort analysis shows adding everolimus to calcineurin inhibitors lowers malignancy risk but increases infection rates.
Transplantation
Narrative Review
Quantiferon-CMV Guided Prophylaxis Fails to Lower Infection in Seropositive Kidney Recipients
Early post-transplant immune monitoring did not reduce infection rates compared to standard preemptive therapy in low-risk patients.
Transplantation
Non-Randomized Controlled Trial
Immune-Guided Strategy Reduces CMV Disease in Kidney Transplant Recipients
Early assessment of cell-mediated immunity allows for targeted prophylaxis, lowering symptomatic disease rates in seropositive patients.
Transplantation
Cohort Study
Pre-Diagnosis FEV1 Decline Predicts Lung Transplant Survival
The rate of lung function loss in the three months before chronic lung allograft dysfunction onset identifies high-risk patients.
Transplantation
Cohort Study
Pre-Diagnosis FEV1 Decline Predicts Mortality in Lung Transplant Recipients
A 20-year cohort study shows that the rate of lung function loss before CLAD onset identifies patients at high risk for rapid progression.